Literature DB >> 15155639

Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide.

Tom Sprong1, Anne-Sophie W Møller, Anna Bjerre, Elisabeth Wedege, Peter Kierulf, Jos W M van der Meer, Petter Brandtzaeg, Marcel van Deuren, T E Mollnes.   

Abstract

Fulminant meningococcal sepsis has been termed the prototypical lipopolysaccharide (LPS)-mediated gram-negative septic shock. Systemic inflammation by activated complement and cytokines is important in the pathogenesis of this disease. We investigated the involvement of meningococcal LPS in complement activation, complement-dependent inflammatory effects, and cytokine or chemokine production. Whole blood anticoagulated with lepirudin was stimulated with wild-type Neisseria meningitidis H44/76 (LPS+), LPS-deficient N. meningitidis H44/76lpxA (LPS-), or purified meningococcal LPS (NmLPS) at concentrations that were relevant to meningococcal sepsis. Complement activation products, chemokines, and cytokines were measured by enzyme-linked immunosorbent assays, and granulocyte CR3 (CD11b/CD18) upregulation and oxidative burst were measured by flow cytometry. The LPS+ and LPS- N. meningitidis strains both activated complement effectively and to comparable extents. Purified NmLPS, used at a concentration matched to the amount present in whole bacteria, did not induce any complement activation. Both CR3 upregulation and oxidative burst were also induced, independent of LPS. Interleukin-1beta (IL-1beta), tumor necrosis factor alpha, and macrophage inflammatory protein 1alpha production was predominantly dependent on LPS, in contrast to IL-8 production, which was also markedly induced by the LPS- meningococci. In this whole blood model of meningococcal sepsis, complement activation and the immediate complement-dependent inflammatory effects of CR3 upregulation and oxidative burst occurred independent of LPS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155639      PMCID: PMC415700          DOI: 10.1128/IAI.72.6.3344-3349.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway.

Authors:  G J Wolbink; J Bollen; J W Baars; R J ten Berge; A J Swaak; J Paardekooper; C E Hack
Journal:  J Immunol Methods       Date:  1993-07-06       Impact factor: 2.303

2.  Complement activation and endotoxin levels in systemic meningococcal disease.

Authors:  P Brandtzaeg; T E Mollnes; P Kierulf
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

3.  Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages.

Authors:  J M Cavaillon; C Fitting; N Haeffner-Cavaillon
Journal:  Eur J Immunol       Date:  1990-02       Impact factor: 5.532

4.  Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

Authors:  S J van Deventer; H R Büller; J W ten Cate; L A Aarden; C E Hack; A Sturk
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

Review 5.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

6.  Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.

Authors:  D van Leenen; T van der Poll; M Levi; H ten Cate; S J van Deventer; C E Hack; L A Aarden; J W ten Cate
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

7.  Complement levels in septic primates treated with anti-C5a antibodies.

Authors:  D H Hangen; J H Stevens; P S Satoh; E W Hall; P T O'Hanley; T A Raffin
Journal:  J Surg Res       Date:  1989-03       Impact factor: 2.192

8.  Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease.

Authors:  A Halstensen; M Ceska; P Brandtzaeg; H Redl; A Naess; A Waage
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

9.  Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins.

Authors:  E Wedege; R Dalseg; D A Caugant; J T Poolman; L O Frøholm
Journal:  J Med Microbiol       Date:  1993-01       Impact factor: 2.472

10.  Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.

Authors:  J H Fredriksen; E Rosenqvist; E Wedege; K Bryn; G Bjune; L O Frøholm; A K Lindbak; B Møgster; E Namork; U Rye
Journal:  NIPH Ann       Date:  1991-12
View more
  12 in total

Review 1.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

2.  Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation.

Authors:  Bernt Christian Hellerud; Jørgen Stenvik; Terje Espevik; John D Lambris; Tom Eirik Mollnes; Petter Brandtzaeg
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

3.  P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner.

Authors:  Nicolas S Merle; Romain Paule; Juliette Leon; Marie Daugan; Tania Robe-Rybkine; Victoria Poillerat; Carine Torset; Véronique Frémeaux-Bacchi; Jordan D Dimitrov; Lubka T Roumenina
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-08       Impact factor: 11.205

4.  Comparative effects of early randomized immune or non-immune-enhancing enteral nutrition on cytokine production in children with septic shock.

Authors:  George Briassoulis; Olga Filippou; Maria Kanariou; Tassos Hatzis
Journal:  Intensive Care Med       Date:  2005-04-16       Impact factor: 17.440

5.  Neutralization of Neisseria meningitidis outer membrane vesicles.

Authors:  András Vida; Annet Troelstra; Péter Antal-Szalmás; Toon J P van Bommel; André F M Verheul; Jan Verhoef; Kok P M van Kessel; Jos A G van Strijp
Journal:  Inflamm Res       Date:  2011-05-24       Impact factor: 4.575

6.  Complement activation and cytokine response by BioProtein, a bacterial single cell protein.

Authors:  L I B Sikkeland; E B Thorgersen; T Haug; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

7.  MyD88-dependent signaling affects the development of meningococcal sepsis by nonlipooligosaccharide ligands.

Authors:  Laura Plant; Hong Wan; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

8.  Human Endothelial Cell Activation by Escherichia coli and Staphylococcus aureus Is Mediated by TNF and IL-1β Secondarily to Activation of C5 and CD14 in Whole Blood.

Authors:  Stig Nymo; Alice Gustavsen; Per H Nilsson; Corinna Lau; Terje Espevik; Tom Eirik Mollnes
Journal:  J Immunol       Date:  2016-01-22       Impact factor: 5.422

9.  Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.

Authors:  Joyce S Plested; Jo Anne Welsch; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2009-04-01

10.  Immune correlates of tuberculosis disease and risk translate across species.

Authors:  Mushtaq Ahmed; Shyamala Thirunavukkarasu; Bruce A Rosa; Kimberly A Thomas; Shibali Das; Javier Rangel-Moreno; Lan Lu; Smriti Mehra; Stanley Kimbung Mbandi; Larissa B Thackray; Michael S Diamond; Kenneth M Murphy; Terry Means; John Martin; Deepak Kaushal; Thomas J Scriba; Makedonka Mitreva; Shabaana A Khader
Journal:  Sci Transl Med       Date:  2020-01-29       Impact factor: 19.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.